91 related articles for article (PubMed ID: 21051579)
1. Localization of metastatic parathyroid carcinoma by 18F FDG PET scanning.
Gardner CJ; Wieshmann H; Gosney J; Carr HM; Macfarlane IA; Cuthbertson DJ
J Clin Endocrinol Metab; 2010 Nov; 95(11):4844-5. PubMed ID: 21051579
[No Abstract] [Full Text] [Related]
2. 18F-FDG PET/CT Osteometabolic Activity in Metastatic Parathyroid Carcinoma.
do Vale RH; Queiroz MA; Coutinho AM; Buchpiguel CA; de Menezes MR
Clin Nucl Med; 2016 Sep; 41(9):724-5. PubMed ID: 27276208
[TBL] [Abstract][Full Text] [Related]
3. Radiographic findings in recurrent parathyroid carcinoma.
Krudy AG; Doppman JL; Marx SJ; Brennan MF; Spiegel A; Aurback GD
Radiology; 1982 Mar; 142(3):625-9. PubMed ID: 7063676
[TBL] [Abstract][Full Text] [Related]
4. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
Neumann DR; Esselstyn CB; Kim EY
J Nucl Med; 1996 Dec; 37(12):2000-1. PubMed ID: 8970522
[TBL] [Abstract][Full Text] [Related]
5. In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Sarlis NJ; Gourgiotis L; Guthrie LC; Galen B; Skarulis MC; Shawker TH; Patronas NJ; Reynolds JC
Clin Nucl Med; 2003 Mar; 28(3):208-17. PubMed ID: 12592128
[TBL] [Abstract][Full Text] [Related]
6. Metastasis of the gastrointestinal tract: FDG-PET imaging.
Hayasaka K; Nihashi T; Matsuura T; Yagi T; Nakashima K; Kawabata Y; Ito K; Katoh T; Sakata K; Harada A
Ann Nucl Med; 2007 Aug; 21(6):361-5. PubMed ID: 17705017
[TBL] [Abstract][Full Text] [Related]
7. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Ryu SY; Kim MH; Choi SC; Choi CW; Lee KH
J Nucl Med; 2003 Mar; 44(3):347-52. PubMed ID: 12620999
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid carcinoma with multiple lung metastases.
Tseng CC; Huang JJ; Wang MC; Lan RR; Sung JM; Chen FF
Nephrol Dial Transplant; 1999 Feb; 14(2):449-51. PubMed ID: 10069211
[No Abstract] [Full Text] [Related]
9. Hypercalcaemic encephalopathy due to metastatic parathyroid carcinoma.
Sadacharan D; Mahadevan S; Ferdinant J; Rakeshchandru K
BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28566413
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary lymphangitic carcinomatosis (PLC): spectrum of FDG-PET findings.
Acikgoz G; Kim SM; Houseni M; Cermik TF; Intenzo CM; Alavi A
Clin Nucl Med; 2006 Nov; 31(11):673-8. PubMed ID: 17053382
[TBL] [Abstract][Full Text] [Related]
11. How high can the standardized uptake value be?
Hickeson M; Zhuang H; Chacko TK; Alavi A
Clin Nucl Med; 2002 Nov; 27(11):819. PubMed ID: 12394139
[No Abstract] [Full Text] [Related]
12. Nonfunctioning parathyroid carcinoma.
Klink BK; Karulf RE; Maimon WN; Peoples JB
Am Surg; 1991 Jul; 57(7):463-7. PubMed ID: 1647716
[TBL] [Abstract][Full Text] [Related]
13. Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma.
Betea D; Bradwell AR; Harvey TC; Mead GP; Schmidt-Gayk H; Ghaye B; Daly AF; Beckers A
J Clin Endocrinol Metab; 2004 Jul; 89(7):3413-20. PubMed ID: 15240624
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m MIBI uptake in recurrent parathyroid carcinoma and brown tumors.
Lu G; Shih WJ; Xiu JY
J Nucl Med; 1995 May; 36(5):811-3. PubMed ID: 7738654
[TBL] [Abstract][Full Text] [Related]
15. Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer.
Posther KE; McCall LM; Harpole DH; Reed CE; Putnam JB; Rusch VW; Siegel BA
J Nucl Med; 2006 Oct; 47(10):1607-11. PubMed ID: 17015895
[TBL] [Abstract][Full Text] [Related]
16. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
17. [Impact of an additional inspiration CT scan on the conventional protocol of the ¹⁸F-FDG PET-CT in the detection of small pulmonary nodes].
García JR; Lozano P; Soler M; Alvarez Moro FJ; Fuertes S; Arribas C; Riera E; Lomeña F
Rev Esp Med Nucl; 2010; 29(6):285-8. PubMed ID: 20702003
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence.
Ng SH; Joseph CT; Chan SC; Ko SF; Wang HM; Liao CT; Chang YC; Lin WJ; Fu YK; Yen TC
J Nucl Med; 2004 Oct; 45(10):1669-76. PubMed ID: 15471831
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid carcinoma visualized by gallium-67 citrate scintigraphy.
Iwase M; Shimizu Y; Kitahara H; Tobioka N; Takatsuki K
J Nucl Med; 1986 Jan; 27(1):63-5. PubMed ID: 3455718
[TBL] [Abstract][Full Text] [Related]
20. The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules.
Fortes DL; Allen MS; Lowe VJ; Shen KR; Wigle DA; Cassivi SD; Nichols FC; Deschamps C
Eur J Cardiothorac Surg; 2008 Dec; 34(6):1223-7. PubMed ID: 18848459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
